ViroGates A/S
CSE:VIRO

Watchlist Manager

ViroGates A/S

CSE:VIRO

Watchlist

Dividends

Discount Rate

Price: 9.3 DKK 3.91% Market Closed

Market Cap: 59.9m DKK

Have any thoughts about
ViroGates A/S?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US		Fubotv Inc NYSE:FUBO	Media
US		Bank of America Corp NYSE:BAC	Banking
US		Palantir Technologies Inc NYSE:PLTR	Technology
US	C	C3.ai Inc NYSE:AI	Technology
US		Uber Technologies Inc NYSE:UBER	Road & Rail
CN		NIO Inc NYSE:NIO	Automobiles
US		Fluor Corp NYSE:FLR	Construction
US		Jacobs Engineering Group Inc NYSE:J	Professional Services
US		TopBuild Corp NYSE:BLD	Consumer products
US		Abbott Laboratories NYSE:ABT	Health Care
US		Chevron Corp NYSE:CVX	Energy
US		Occidental Petroleum Corp NYSE:OXY	Energy
US		Matrix Service Co NASDAQ:MTRX	Construction
US		Automatic Data Processing Inc NASDAQ:ADP	Technology
US		Qualcomm Inc NASDAQ:QCOM	Semiconductors
US		Ambarella Inc NASDAQ:AMBA	Semiconductors

Add Price Alert

Price Target:

Last Price: 9.3 DKK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

VIRO Alert

ViroGates A/S

9.3

+0.35 (+3.91%)

52 Week Range	5.4 9.3
Price Target

We'll email you a reminder when the closing price reaches DKK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Fubotv Inc NYSE:FUBO	US
	Bank of America Corp NYSE:BAC	US
	Palantir Technologies Inc NYSE:PLTR	US
C	C3.ai Inc NYSE:AI	US
	Uber Technologies Inc NYSE:UBER	US
	NIO Inc NYSE:NIO	CN
	Fluor Corp NYSE:FLR	US
	Jacobs Engineering Group Inc NYSE:J	US
	TopBuild Corp NYSE:BLD	US
	Abbott Laboratories NYSE:ABT	US
	Chevron Corp NYSE:CVX	US
	Occidental Petroleum Corp NYSE:OXY	US
	Matrix Service Co NASDAQ:MTRX	US
	Automatic Data Processing Inc NASDAQ:ADP	US
	Qualcomm Inc NASDAQ:QCOM	US
	Ambarella Inc NASDAQ:AMBA	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

ViroGates A/S

What unique competitive advantages
does ViroGates A/S hold over its rivals?

What risks and challenges
does ViroGates A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of ViroGates A/S.

What unique competitive advantages
does ViroGates A/S hold over its rivals?

What risks and challenges
does ViroGates A/S face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for ViroGates A/S.

Provide P/S
for ViroGates A/S.

Provide P/E
for ViroGates A/S.

Provide P/OCF
for ViroGates A/S.

Provide P/FCFE
for ViroGates A/S.

Provide P/B
for ViroGates A/S.

Provide EV/S
for ViroGates A/S.

Provide EV/GP
for ViroGates A/S.

Provide EV/EBITDA
for ViroGates A/S.

Provide EV/EBIT
for ViroGates A/S.

Provide EV/OCF
for ViroGates A/S.

Provide EV/FCFF
for ViroGates A/S.

Provide EV/IC
for ViroGates A/S.

Compare the intrinsic valuations
of ViroGates A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of ViroGates A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of ViroGates A/S compared to its peers.

Compare the P/E ratios
of ViroGates A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing ViroGates A/S with its peers.

Analyze the financial leverage
of ViroGates A/S compared to its main competitors.

Show all profitability ratios
for ViroGates A/S.

Provide ROE
for ViroGates A/S.

Provide ROA
for ViroGates A/S.

Provide ROIC
for ViroGates A/S.

Provide ROCE
for ViroGates A/S.

Provide Gross Margin
for ViroGates A/S.

Provide Operating Margin
for ViroGates A/S.

Provide Net Margin
for ViroGates A/S.

Provide FCF Margin
for ViroGates A/S.

Show all solvency ratios
for ViroGates A/S.

Provide D/E Ratio
for ViroGates A/S.

Provide D/A Ratio
for ViroGates A/S.

Provide Interest Coverage Ratio
for ViroGates A/S.

Provide Altman Z-Score Ratio
for ViroGates A/S.

Provide Quick Ratio
for ViroGates A/S.

Provide Current Ratio
for ViroGates A/S.

Provide Cash Ratio
for ViroGates A/S.

What is the historical Revenue growth
over the last 5 years for ViroGates A/S?

What is the historical Net Income growth
over the last 5 years for ViroGates A/S?

What is the current Free Cash Flow
of ViroGates A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for ViroGates A/S.

Financials Section:

Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

Balance Sheet Decomposition
ViroGates A/S

Current Assets	15.8m
Cash & Short-Term Investments	8.7m
Receivables	2.7m
Other Current Assets	4.4m
Non-Current Assets	176k
Other Non-Current Assets	176k

Current Liabilities	1.3m
Accounts Payable	541k
Other Current Liabilities	803k
Non-Current Liabilities	5.3m
Long-Term Debt	5.3m

Balance Sheet
ViroGates A/S

Rotate your device to view
Balance Sheet

Currency: DKK

	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023
Assets
Cash & Cash Equivalents	15	8	1	60	41	34	15	10	16
Cash Equivalents	15	8	1	60	41	34	15	10	16
Total Receivables	2	3	2	2	2	3	3	4	3
Accounts Receivables	1	2	0	0	0	2	1	2	2
Other Receivables	1	2	2	2	2	2	2	2	1
Inventory	0	0	1	1	0	1	2	4	5
Other Current Assets	0	0	0	0	0	0	0	0	0
Total Current Assets	17	12	5	63	44	38	20	17	24
PP&E Net	0	0	0	0	1	0	0	0	0
Note Receivable	0	0	0	0	0	0	0	0	0
Other Long-Term Assets	0	0	0	0	0	0	0	0	0
Total Assets	17 N/A	12 -31%	5 -59%	63 +1 174%	45 -29%	38 -15%	20 -47%	18 -13%	25 +40%
Liabilities
Accounts Payable	1	1	0	0	1	4	0	1	2
Short-Term Debt	0	0	0	0	0	0	0	0	0
Other Current Liabilities	2	2	2	2	2	3	3	1	1
Total Current Liabilities	3	3	2	2	3	7	4	1	2
Long-Term Debt	0	0	0	0	0	0	0	0	5
Other Liabilities	0	0	0	0	0	0	0	0	0
Total Liabilities	3 N/A	3 0%	2 -34%	2 +22%	3 +22%	7 +136%	4 -45%	1 -62%	8 +420%
Equity
Common Stock	2	2	2	3	3	3	3	3	0
Retained Earnings	12	7	1	58	39	28	13	13	0
Other Equity	0	0	0	0	0	0	0	0	17
Total Equity	14 N/A	9 -38%	3 -67%	61 +1 936%	42 -31%	31 -26%	16 -48%	16 -2%	17 +6%
Total Liabilities & Equity	17 N/A	12 -31%	5 -59%	63 +1 174%	45 -29%	38 -15%	20 -47%	18 -13%	25 +40%
Shares Outstanding
Common Shares Outstanding	2	2	2	3	3	4	4	4	6

Switch to:

Income Statement Balance Sheet Cash Flow Statement

Switch to:

Income Statement Balance Sheet Cash Flow Statement

ViroGates A/S
CSE:VIRO

Balance Sheet

Balance Sheet Decomposition
ViroGates A/S

Balance Sheet
ViroGates A/S

See Also

Company

Help

Tools

Stocks

ViroGates A/S CSE:VIRO

Balance Sheet

Balance Sheet Decomposition ViroGates A/S

Balance Sheet ViroGates A/S

See Also

Company

Help

Tools

Stocks

ViroGates A/S
CSE:VIRO

Balance Sheet Decomposition
ViroGates A/S

Balance Sheet
ViroGates A/S